Agrawal S, Yu L, Kapasi A, James BD, Arfanakis K, Barnes LL et al (2021) Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons. Brain Pathol 31:e12939. https://doi.org/10.1111/bpa.12939

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akiyama T, Koike Y, Petrucelli L, Gitler AD (2022) Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: towards therapeutic targets and biomarkers. Clin Transl Med 12(5):e818. https://doi.org/10.1002/ctm2.818

Article  CAS  PubMed  PubMed Central  Google Scholar 

Altuna M (2024) Limbic-predominant age-related TDP-43 encephalopathy: amnestic-predominant cognitive decline beyond Alzheimer’s disease. Adv Neurol 3:2603. https://doi.org/10.36922/an.2603

Article  CAS  Google Scholar 

Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R et al (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 61(5):435–445. https://doi.org/10.1002/ana.21154

Article  CAS  PubMed  PubMed Central  Google Scholar 

An J, Gopalakrishnan L, Ortega V, Saul J, Kadali R, Bowser R (2024) Development of a sensitive and reliable Meso Scale Discovery-based electrochemiluminescence immunoassay to quantify TDP-43 in human biofluids. Biosensors 14(12):578. https://doi.org/10.3390/bios14120578

Article  CAS  PubMed  Google Scholar 

Arezoumandan S, Cai X, Kalkarni P, Davis SA, Wilson K, Ferris CF et al (2021) Hippocampal neurobiology and function in an aged mouse model of TDP-43 proteinopathy in an APP/PSEN1 background. Neurosci Lett 758:136010. https://doi.org/10.1016/j.neulet.2021.136010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arseni D, Chen R, Murzin AG, Peak-Chew SY, Garringer HJ, Newell KL et al (2023) TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP. Nature 620(7975):898–903. https://doi.org/10.1038/s41586-023-06405-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Attems J, Thal DR, Jellinger KA (2012) The relationship between subcortical tau pathology and Alzheimer’s disease. Biochem Soc Trans 40:711–715. https://doi.org/10.1042/BST20120034

Article  CAS  PubMed  Google Scholar 

Bauer CE, Zachariou V, Sudduth TL, Van Eldik LJ, Jicha GA, Nelson PT et al (2023) Plasma TDP-43 levels are associated with neuroimaging measures of brain structure in limbic regions. Alzheimers Dement (Amst) 15:e12437. https://doi.org/10.1002/dad2.12437

Article  PubMed  PubMed Central  Google Scholar 

Besser LM, Teylan MA, Nelson PT (2020) Limbic predominant age-related TDP-43 encephalopathy (LATE): clinical and neuropathological associations. J Neuropathol Exp Neurol 79:305–313. https://doi.org/10.1093/jnen/nlz126

Article  CAS  PubMed  PubMed Central  Google Scholar 

Botha H, Mantyh WG, Murray ME, Knopman DS, Przybelski SA, Wiste HJ et al (2018) FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis. Brain 141(4):1201–1217. https://doi.org/10.1093/brain/awy049

Article  PubMed  PubMed Central  Google Scholar 

Boyle PA, Yang J, Yu L, Leurgans SE, Capuano AW, Schneider JA et al (2017) Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline. Brain 140(3):804–812. https://doi.org/10.1093/brain/aww341

Article  PubMed  PubMed Central  Google Scholar 

Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239–259. https://doi.org/10.1007/BF00308809

Article  CAS  PubMed  Google Scholar 

Buciuc M, Botha H, Murray ME, Schwarz CG, Senjem ML, Jones DT et al (2020) Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy. Neurology 95(1):e23–e34. https://doi.org/10.1212/WNL.0000000000009722

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buciuc M, Tosakulwong N, Machulda MM, Whitwell JL, Weigand SD, Murray ME et al (2021) TAR DNA-Binding Protein 43 is associated with rate of memory, functional and global cognitive decline in the decade prior to death. J Alzheimers Dis 80(2):683–693. https://doi.org/10.3233/JAD-201166

Article  CAS  PubMed  Google Scholar 

Butler Pagnotti RM, Pudumjee SB, Cross CL, Miller JB (2023) Cognitive and clinical characteristics of patients with limbic-predominant age-related TDP-43 encephalopathy. Neurology 100:e2027–e2035. https://doi.org/10.1212/WNL.0000000000207159

Article  PubMed  PubMed Central  Google Scholar 

Calliari A, Daughrity LM, Albagli EA, Castellanos Otero P, Yue M, Jansen-West K et al (2024) HDGFL2 cryptic proteins report presence of TDP-43 pathology in neurodegenerative diseases. Mol Neurodegener 19(1):29. https://doi.org/10.1186/s13024-024-00718-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carlos AF, Sekiya H, Koga S, Gatto RG, Casey MC, Pham NTT et al (2023) Clinicopathologic features of a novel star-shaped transactive response DNA-binding protein 43 (TDP-43) pathology in the oldest old. J Neuropathol Exp Neurol 83(1):36–52. https://doi.org/10.1093/jnen/nlad105

Article  PubMed  PubMed Central  Google Scholar 

Carlos AF, Weigand SD, Pham NTT, Petersen RC, Jack CR Jr, Dickson DW et al (2025) White matter hyperintensities and TDP-43 pathology in Alzheimer’s disease. Alzheimers Dement 21(2):ealz14516. https://doi.org/10.1002/alz.14516

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cervantes González A, Irwin DJ, Alcolea D, McMillan CT, Chen‑Plotkin A, Wolk D et al (2022) Multimarker synaptic protein cerebrospinal fluid panels reflect TDP‑43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration. Mol Neurodegener 17:29. https://doi.org/10.1186/s13024-022-00534-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang K, Ling JP, Redding-Ochoa J, An Y, Li L, Dean SA et al (2023) Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer’s disease neuropathologic changes and cognitive decline. Acta Neuropathol 147(1):4. https://doi.org/10.1007/s00401-023-02653-2

Article  CAS  PubMed  Google Scholar 

Chornenkyy Y, Fardo DW, Nelson PT (2019) Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy. Lab Invest 99(7):993–1007. https://doi.org/10.1038/s41374-019-0196-y

Article  PubMed  PubMed Central  Google Scholar 

Chung M, Carter EK, Veire AM, Dammer EB, Chang J, Duong DM et al (2024) Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains. Acta Neuropathol 147:29–45. https://doi.org/10.1007/s00401-023-02671-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cohen TJ, Hwang AW, Restrepo CR, Yuan CX, Trojanowski JQ, Lee VM (2015) An acetylation switch controls TDP-43 function and aggregation propensity. Nat Commun 6:5845. https://doi.org/10.1038/ncomms6845

Article  CAS  PubMed  PubMed Central  Google Scholar 

Connolly EE, Ervin JF, Plassman BL, Welsh-Bohmer KA, Wang SJ (2025) Star-shaped TDP-43 inclusions in the oldest-old. J Neuropathol Exp Neurol 84(4):356–359. https://doi.org/10.1093/jnen/nlae116

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cordts I, Wachinger A, Scialo C, Lingor P, Polymenidou M, Buratti E et al (2023) TDP-43 proteinopathy specific biomarker development. Cells 12:597. https://doi.org/10.3390/cells12040597

Article  CAS